.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

DEPAKOTE Drug Profile

« Back to Dashboard

Which patents cover Depakote, and what substitute generic drugs are available?

Depakote is a drug marketed by Abbvie and Abbott and is included in four NDAs. There are six patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in DEPAKOTE is divalproex sodium. There are seventeen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

Summary for Tradename: DEPAKOTE

Patents:0
Applicants:2
NDAs:4
Suppliers / Packagers: see list4
Bulk Api Vendors: see list33
Clinical Trials: see list23
Patent Applications: see list2,845
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEPAKOTE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
DEPAKOTE
divalproex sodium
TABLET, DELAYED RELEASE;ORAL018723-003Oct 26, 1984RXYesNo► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002RXYesNo6,511,678*PED► SubscribeY► Subscribe
Abbvie
DEPAKOTE
divalproex sodium
CAPSULE, DELAYED REL PELLETS;ORAL019680-001Sep 12, 1989RXYesYes► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000RXYesYes6,511,678*PED► SubscribeY► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002RXYesNo6,528,090*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DEPAKOTE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
DEPAKOTE
divalproex sodium
TABLET, DELAYED RELEASE;ORAL018723-003Oct 26, 19844,988,731*PED► Subscribe
Abbvie
DEPAKOTE
divalproex sodium
TABLET, DELAYED RELEASE;ORAL018723-002Mar 10, 19835,212,326*PED► Subscribe
Abbvie
DEPAKOTE
divalproex sodium
CAPSULE, DELAYED REL PELLETS;ORAL019680-001Sep 12, 19895,212,326*PED► Subscribe
Abbvie
DEPAKOTE
divalproex sodium
TABLET, DELAYED RELEASE;ORAL018723-003Oct 26, 19845,212,326*PED► Subscribe
Abbvie
DEPAKOTE
divalproex sodium
TABLET, DELAYED RELEASE;ORAL018723-002Mar 10, 19834,988,731*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: DEPAKOTE

Drugname Dosage Strength RLD Submissiondate
divalproex sodiumExtended-release Tablets500 mgDepakote ER2/8/2005
divalproex sodiumExtended-release Tablets250 mgDepakote ER5/3/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc